JoVE Logo

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Erratum Notice
  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Erratum
  • Reprints and Permissions

Erratum Notice

Important: There has been an erratum issued for this article. Read More ...

Summary

While replication fork collisions with DNA adducts can induce double strand breaks, less is known about the interaction between replisomes and blocking lesions. We have employed the proximity ligation assay to visualize these encounters and to characterize the consequences for replisome composition.

Abstract

Considerable insight is present into the cellular response to double strand breaks (DSBs), induced by nucleases, radiation, and other DNA breakers. In part, this reflects the availability of methods for the identification of break sites, and characterization of factors recruited to DSBs at those sequences. However, DSBs also appear as intermediates during the processing of DNA adducts formed by compounds that do not directly cause breaks, and do not react at specific sequence sites. Consequently, for most of these agents, technologies that permit the analysis of binding interactions with response factors and repair proteins are unknown. For example, DNA interstrand crosslinks (ICLs) can provoke breaks following replication fork encounters. Although formed by drugs widely used as cancer chemotherapeutics, there has been no methodology for monitoring their interactions with replication proteins.

Here, we describe our strategy for following the cellular response to fork collisions with these challenging adducts. We linked a steroid antigen to psoralen, which forms photoactivation dependent ICLs in nuclei of living cells. The ICLs were visualized by immunofluorescence against the antigen tag. The tag can also be a partner in the Proximity Ligation Assay (PLA) which reports the close association of two antigens. The PLA was exploited to distinguish proteins that were closely associated with the tagged ICLs from those that were not. It was possible to define replisome proteins that were retained after encounters with ICLs and identify others that were lost. This approach is applicable to any structure or DNA adduct that can be detected immunologically.

Introduction

The cellular response to double strand breaks is well documented owing to a succession of increasingly powerful methods for directing breaks to specific genomic sites1,2,3. The certainty of location enables unambiguous characterization of proteins and other factors that accumulate at the site and participate in the DNA Damage Response (DDR) thereby driving the Non-Homologous End Joining (NHEJ) and Homologous Recombination (HR) pathways that repair breaks. Of course, many breaks are introduced by agents such as radiation and chemical species that do not attack specific sequences4. However, for these there are procedures available that can convert the ends to structures amenable for tagging and localization5,6. Breaks are also introduced by biological processes, such as immunoglobulin rearrangement, and recent technology permits their localization, as well7. The relationship between responding factors and those sites can then be determined.

Breaks also appear as an indirect consequence of adducts formed by compounds that are not inherent breakers but disrupt DNA transactions such as transcription and replication. They may be formed as a feature of the cellular response to these obstructions, perhaps during repair or because they provoke a structure that is vulnerable to nuclease attack. Typically, the physical relationship between the adduct, the break, and the association with responding factors is inferential. For example, ICLs are formed by chemotherapeutics such as cisplatin and Mitomycin C8 and as a reaction product of abasic sites9. ICLs are well known as potent blocks to replication forks10, thereby stalling forks which can be cleaved by nucleases11. The covalent linkage between strands is often relieved by pathways that have obligate breaks as intermediates12,13, necessitating homologous recombination to rebuild the replication fork14. In most experiments the investigator follows the response of factors of interest to the breaks which are formed downstream of the collision of a replication fork with an ICL. However, because there has been no technology for the localization of a provocative lesion, the proximity of the replisome, and its component parts, to the ICL can only be assumed.

We have developed a strategy to enable the analysis of protein associations with non-sequence specific covalent adducts, illustrated here by ICLs. In our system these are introduced by psoralen, a photoactive natural product used for thousands of years as a therapeutic for skin disorders15. Our approach is based on two important features of psoralens. The first is their high frequency of crosslink formation, which can exceed 90% of adducts, in contrast to the less than 10% formed by popular compounds such as cisplatin or Mitomycin C8,16. The second is the accessibility of the compound to conjugation without loss of crosslinking capacity. We have covalently linked trimethyl psoralen to Digoxigenin (Dig), a long established immunotag. This enables detection of the psoralen adducts in genomic DNA by immunostaining of the Dig tag, and visualization by conventional immunofluorescence17.

This reagent was applied, in our previous work, to the analysis of replication fork encounters with ICLs using a DNA fiber-based assay16. In that work we found that replication could continue past an intact ICL. This was dependent on the ATR kinase, which is activated by replication stress. The replication restart was unexpected given the structure of the CMG replicative helicase. This consists of the MCM hetero-hexamer (M) that forms an offset gapped ring around the template strand for leading strand synthesis which is locked by the proteins of the GINS complex (G, consisting of PSF1, 2, 3, and SLD5) and CDC45 (C)18. The proposal that replication could restart on the side of the ICL distal to the side of the replisome collision argued for a change in the structure of the replisome. To address the question of which components were in the replisome at the time of the encounter with an ICL we developed the approach described here. We exploited the Dig tag as a partner in Proximity Ligation Assays (PLA)19 to interrogate the close association of the ICL with proteins of the replisome20.

Protocol

1. Cell preparation

  1. Day 1
    1. Pre-treat 35 mm glass-bottomed culture dishes with a cell adhesive solution.
    2. Plate cells in the pre-treated dishes one day before treatment. Cell should be actively dividing and 50–70% confluent on the day of the experiment.
      NOTE: HeLa cells were used in this experiment with Dulbecco Modified Eagle Medium DMEM, supplemented with 10% fetal bovine serum, 1x penicillin /streptomycin. There is no restriction for adherent cell lines. However, non-adherent cells must be centrifuged onto slides and fixed prior to the analysis by PLA.
  2. Day 2
    1. Prepare a stock solution of Digoxigenin Trimethyl psoralen (Dig-TMP) by resuspending a frozen aliquot of previously synthesized Dig-TMP in 1:1 EtOH:H2O. Determine the concentration by measuring OD at 250 nm of a 100x dilution (in H2O) of the dissolved Dig-TMP. The extinction coefficient of Dig-TMP is 25,000. Verify the concentration by measuring OD at 250 nm before each use and calculate stock concentration: Abs x 100 x 106/25,000 = Concentration (in µM). Generally, the stock solution is around 3 mM. The solution can be stored in –20 °C for about a month.
      NOTE: Dig-TMP must be chemically synthesized in advance, following the procedure described here. Reflux 4'-chloromethyl-4,5',8-trimethylpsoralen with 4,7,10-trioxa-1,13-tridecanedi-amine in toluene under nitrogen for 12 h. Remove the solvent and recover the 4'-[N-(13-amino-4,7,10-trioxatrideca)] aminomethyl-4,5',8-trimethylpsoralen product by silica gel chromatography. Conjugate the product to digoxigenin NHS ester in dimethyl formamide and triethylamine at 50 °C for 18 h. Remove the solvent and purify the residue by preparative thin layer silica gel chromatography. Elute the product band chloroform: methanol: 28% ammonium hydroxide (8:1:0.1) mixture. Evaporate the solvents and dissolve the pellet in 50% EtOH:H2O.
    2. Add Dig-TMP stock in 50% EtOH:H2O to the cell culture medium to a final concentration of 5 µM. Bring the medium to 37 °C. Aspirate the medium from the plates, add the pre-warmed Dig-TMP containing media, and place plates in an incubator (37 °C, 5% CO2) for 30 min to allow the Dig-TMP to equilibrate.
    3. While the cells are incubating, pre-warm the UV box (see Table of Materials) to 37 °C.
    4. Place the plates in the pre-warmed UV box and expose the cells to a dose of 3 J/cm2 of UVA light for 5 min for this experiment. Plates were placed on top of a thermo-block maintained at 37 °C, during irradiation. Calculate the time using the formula:
      figure-protocol-2805
    5. Aspirate the medium using a pipette, add fresh pre-warmed medium and place plates back in the incubator at 37 °C, 5% CO2 for 1 h.
    6. Remove media and wash dishes once gently with phosphate buffered saline (PBS).
    7. Remove PBS and add 0.1% formaldehyde (FA) in PBS for 5 min at room temperature (RT). This prevents cell detachment during CSK-R (cytoskeleton extraction buffer containing RNase, described in 1.2.9.) pretreatment required to extract the cytoplasmic elements and reduce PLA background.
    8. Aspirate off FA and wash dishes with PBS once.
    9. Add CSK-R buffer and incubate for 5 min at RT to remove cytoplasm [CSK-R buffer: 10 mM PIPES, pH 7.0, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl2, 0.5%Triton X-100, 300 µg/mL RNase A]. Aspirate the buffer, add fresh CSK-R, and incubate for 5 min at RT.
      NOTE: A stock of CSK buffer can be stored at 4 °C, and Triton X and RNaseA added right before use.
    10. Wash with PBS thrice.
    11. Fix cells with 4% formaldehyde in PBS for 10 min at RT.
    12. Wash cells with PBS. Perform this step three times.
    13. Add cold 100% methanol and incubate for 20 min at -20 °C.
    14. Wash cells with PBS thrice. At this point cells can be stored in PBS in a humid chamber at 4 °C for up to a week.
    15. Incubate cells in 80 µL of 5 mM TritonX-100 for 10 min at 4 °C.
    16. Incubate cells with 100 µL of 5 mM EDTA in PBS supplemented with 1 µL of 100 mg/mL RNase A for 30 min at 37 °C.
    17. Wash cells with PBS thrice.
    18. Store cells in blocking buffer (5% BSA and 10% goat serum in PBS) in a humid chamber overnight at 4 °C.

2. Proximity ligation assay

NOTE: Perform proximity ligation assay on Day 3.

  1. Antibody staining
    1. Prepare 40 μL of the primary antibody solution per plate: Add the appropriate volume of primary antibodies to achieve desired dilution (mouse anti Digoxigenin and rabbit antibody against a replisome component such as MCM5, CDC45, PSF1 or pMCM2, dilutions specified in Table of Materials) into blocking buffer (to reach a final volume of 24 μL). Mix by tapping and let it stand for 20 min at RT. Prepare a master mix for multiple samples and mix by tapping before applying to the wells.
    2. Add 40 μL of primary antibody solution to the center of the well and incubate in a humid chamber for 1 h at 37 °C. During staining, allow the PLA probes and blocking buffer to warm to the room temperature.
    3. Wash cells with PBS-T [PBS-T: 0.05% Tween-20 in 1X PBS] at RT. Perform this step three times.
    4. While washing, prepare 40 μL of PLA probe solution per dish (PLA probes consist of a secondary antibody recognizing either rabbit or mouse IgG, covalently linked to a PLUS or MINUS oligonucleotide): 8 μL of PLA probe anti mouse-PLUS + 8 μL of PLA probe anti rabbit-MINUS antibody + 24 μL of blocking buffer. Mix and let it stand for 20 min at RT. Prepare a master mix for multiple samples and mix well before applying to the wells. Place the solution in the middle of the well in the plate.
    5. Remove last wash, add 40 μL of PLA probe solution to the center of the well, and incubate in a humid chamber for 1 h at 37 °C.
    6. Wash in buffer A thrice, for 10 min each, on a tilting platform at RT. During washing, bring the ligation mix to RT.
  2. Ligation and amplification
    1. Prepare 40 μL of Ligation mix per plate: 8 μL (5x) of ligation stock + 31 μL of distilled water + 1 μL of ligase. Prepare master mix for multiple plates and mix well before applying to the wells.
    2. Add 40 μL of ligation solution to each plate and incubate in a humid chamber for 30 min. at 37 °C.
    3. Wash cells 3x with buffer A, each for 2 min, on a tilting platform at RT.
    4. Prepare 40 μL of amplification solution per dish: 8 μL (5x) of amplification stock + 31.5 μL of distilled water + 0.5 μL of DNA Polymerase. Prepare a master mix for multiple samples and mix well before applying to the wells.
    5. Add 40 μL of amplification solution to each plate and incubate in a humid chamber at 37 °C for 100 min.
    6. Aspirate off the amplification solution and wash with buffer B. Perform 6 washes each for 10 min, on a tilting platform at RT.
    7. Wash once with 0.01x buffer B for 1 min at RT.
    8. Aspirate buffer B and incubate plates with secondary antibodies, Alexa Fluor 488 anti-mouse IgG and Alexa Fluor 568 anti-rabbit IgG in blocking solution at appropriate dilutions in blocking buffer, in a humid chamber, for 30 min at 37 °C or overnight at 4 °C.
    9. Wash cells three times with PBS-T, for 10 min each on a tilting platform at RT.
    10. Aspirate PBS-T and mount in mounting medium with DAPI. The mounted plates can be imaged immediately or stored at 4 °C in the dark for no more than 4 days before imaging.

3. Imaging and quantification

  1. Perform imaging in an epifluorescent or confocal microscope (if 3D imaging is desirable, cover at least 3 µm in 15 stacks). Perform experiments in triplicate and image enough number of fields to make at least 100 observations per sample or condition. Image all fields and samples, including controls, using the same exposure settings.
  2. Quantify with an appropriate image analysis software (see Table of Materials for open source and commercial software capable of performing this analysis in single or multiple plane-images).
    1. Segment cell nuclei based on the DAPI staining. Perform detection of nuclear PLA dots. Assign PLA dots to their corresponding nucleus. Export PLA dots per nucleus results as a csv file (see Supplementary File 1 and Supplementary File 2).
  3. Statistical analysis (see Table of Materials for suggested open source and commercial software).
    1. Verify if the samples follow a normal distribution with a Shapiro-Wilk test.
    2. Determine whether there is a significant difference between two samples using a Student-t test (if normal distribution assumption met) or a Wilcoxon-Rank Sum test (if normal distribution assumption is violated for a sample).
  4. Data visualization: Generate dot plots combined with box plots to visualize data distribution, median (Q2), 25th (Q1) and 75th percentile for the different samples (See Table of Materials for suggested open source and commercial software).

4. 3D display of pMCM2: ICL interactions

  1. Image PLA plates on a spinning disk confocal microscope, using a Plan Fluor 60x/1.25 numerical aperture oil objective. Acquire 16 stacks covering 1.6 mm and generate the 3D reconstruction with the appropriate image analysis software (see Table of Materials).

Results

PLA of Dig-TMP with replisome proteins
The structure of the Dig-TMP is shown in Figure 1. The details of the synthesis, in which trimethyl psoralen was conjugated through a glycol linker to digoxigenin, have been discussed previously17,21. Incubation of cells with the compound followed by exposure to 365 nm light (UVA) photoactivates the compound and drives the crosslinking reaction. Slightly more than 90% of a...

Discussion

Although the PLA is a very powerful technique, there are technical concerns that must be solved in order to obtain clear and reproducible results. The antibodies must be of high affinity and specificity. Furthermore, it is important to reduce the non-specific background signals as much as possible. We have found that membranes and cellular debris contribute to the background, and we have removed them as much as possible. The washes with detergent containing buffers prior to fixing, and the wash with methanol after fixing...

Disclosures

The authors have nothing to disclose.

Acknowledgements

This research was supported, in part, by the Intramural Research Program of the NIH, National Institute on Aging, United States (Z01-AG000746–08). J.H. is supported by the National Natural Science Foundations of China (21708007 and 31871365).

Materials

NameCompanyCatalog NumberComments
Alexa Fluor 568, Goat anti-Rabbit IgG (H+L) Cross-Adsorbed Secondary AntibodyInvitrogenA-100111 in 1000
35 mm plates with glass 1.5 coverslipMatTekP35-1.5-14-CGlass Bottom Microwell Dishes 35mm Petri Dish Microwell
Alexa Fluor 488,Goat anti-Mouse IgG (H+L) Cross-Adsorbed Secondary AntibodyInvitrogenA-100011 in 1000
Bovine serum albumin (BSA)SeraCare1900-0012Blocking solution, reagents need to be stored at 4 °C
CDC45 antibody (rabbit)Abcamab1267621 in 200
Cell adhesiveLife Science354240for cell-TAK solution
Confocal microscopeNikkonNikon TE2000 spinning disk microscopeequiped with Volocity software
Digoxigenin (Dig) antibody (mouse)Abcamab4201 in 200
Dig-TMPsynthesized in the Seidman Lab
Duolink Amplification reagents (5×)Sigma-AldrichDUO82010reagents need to be stored at -20 °C
Duolink in situ detection reagentsSigma-AldrichDUO92007reagents need to be stored at -20 °C
Duolink in situ oligonucleotide PLA probe MINUSSigma-AldrichDUO92004anti-mouse MINUS, reagents need to be stored at 4 °C
Duolink in situ oligonucleotide PLA probe PLUSSigma-AldrichDUO92002anti-rabbit PLUS, reagents need to be stored at 4 °C
Duolink in situ wash buffer ASigma-AldrichDUO82046Duolink Wash Buffers, reagents need to be stored at 4 °C
Duolink in situ wash buffer BSigma-AldrichDUO82048Duolink Wash Buffers, reagents need to be stored at 4 °C
epifluorescent microscopeZeissAxiovert 200M microscopeEquipped with the Axio Vision software packages (Zeiss, Germany)
Formaldehyde 16%Fisher ScientificPI28906for fix solution
Goat serumThermo31873Blocking solution, reagents need to be stored at 4 °C
Image analysis softwareopen sourceCell profilerworks for analysis of single plane images
Image analysis software-license requiredBitplaneImarisCell Biology module needed. Can quantify PLA dots/nuclei in image stacks (3D) and do 3D reconstructions
Ligase (1 unit/μl)Sigma-AldrichDUO82029reagents need to be stored at -20 °C
Ligation reagent (5×)Sigma-AldrichDUO82009reagents need to be stored at -20 °C
MCM2 antibody (rabbit)Abcamab44611 in 200
MCM5 antibody (rabbit monoclonal)AbcamAb759751 in 1000
MethanolLab ALLEYA2076pre-cold at -20°C before use
phosphoMCM2S108 antibody (rabbit)Abcamab1092711 in 200
Polymerase (10 unit/μl)Sigma-AldrichDUO82030reagents need to be stored at -20 °C
Prolong gold mounting media with DAPIThermoFisher ScientificP36935
PSF1 antibody (rabbit)Abcamab1811121 in 200
RNAse A 100 mg/mlQiagen19101reagents need to be stored at 4 °C
Statistical analysis and data visualization softwareopen sourceR studioggplot2 package for generation of dot plot and box plots
Statistical analysis and data visualization software-license requiredSystat SoftwareSigmaplot V13
TMP (trioxalen)Sigma-AldrichT6137_1G
TritonX-100Sigma-AldrichT8787_250ML
Tween 20Sigma-AldrichP9416_100ML
UV boxSouthern New England UltravioletDiscontinued. See Opsytec UV test chamber as a possible replacement
UV test ChamberOpsytecUV TEST CHAMBER BS-04
VE-821SelleckchemS8007final concentrtion is 1µM

References

  1. Rouet, P., Smih, F., Jasin, M. Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Molecular and Cellular Biology. 14 (12), 8096-8106 (1994).
  2. Wright, D. A., et al. Standardized reagents and protocols for engineering zinc finger nucleases by modular assembly. Nature Protocols. 1 (3), 1637-1652 (2006).
  3. Brinkman, E. K., et al. Kinetics and fidelity of the repair of Cas9-induced double-strand DNA breaks. Molecular Cell. 70 (5), 801-813 (2018).
  4. Vitor, A. C., Huertas, P., Legube, G., de Almeida, S. F. Studying DNA double-strand break repair: An ever-growing toolbox. Frontiers in Molecular Bioscience. 7, 24 (2020).
  5. Galbiati, A., Beausejour, C., d'Adda di, F. F. A novel single-cell method provides direct evidence of persistent DNA damage in senescent cells and aged mammalian tissues. Aging Cell. 16 (2), 422-427 (2017).
  6. Vitelli, V., et al. Recent Advancements in DNA damage-transcription crosstalk and high-resolution mapping of DNA breaks. Annual Review of Genomics and Human Genetics. 18, 87-113 (2017).
  7. Canela, A., et al. DNA breaks and end resection measured genome-wide by end sequencing. Molecular Cell. 63 (5), 898-911 (2016).
  8. Muniandy, P. A., Liu, J., Majumdar, A., Liu, S. T., Seidman, M. M. DNA interstrand crosslink repair in mammalian cells: step by step. Critical Reviews in Biochemistry and Molecular Biology. 45 (1), 23-49 (2010).
  9. Nejad, M. I., et al. Interstrand DNA cross-links derived from reaction of a 2-aminopurine residue with an abasic site. ACS Chemical Biology. 14 (7), 1481-1489 (2019).
  10. Kottemann, M. C., Smogorzewska, A. Fanconi anaemia and the repair of Watson and Crick DNA crosslinks. Nature. 493 (7432), 356-363 (2013).
  11. Kaushal, S., Freudenreich, C. H. The role of fork stalling and DNA structures in causing chromosome fragility. Genes Chromosomes Cancer. 58 (5), 270-283 (2019).
  12. Knipscheer, P., Raschle, M., Scharer, O. D., Walter, J. C. Replication-coupled DNA interstrand cross-link repair in Xenopus egg extracts. Methods in Molecular Biology. 920, 221-243 (2012).
  13. Klein, D. D., et al. XPF-ERCC1 acts in Unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP/SLX4. Molecular Cell. 54 (3), 460-471 (2014).
  14. Long, D. T., Raschle, M., Joukov, V., Walter, J. C. Mechanism of RAD51-dependent DNA interstrand cross-link repair. Science. 333 (6038), 84-87 (2011).
  15. Benedetto, A. V. The psoralens. An historical perspective. Cutis. 20 (4), 469-471 (1977).
  16. Huang, J., et al. The DNA translocase FANCM/MHF promotes replication traverse of DNA interstrand crosslinks. Molecular Cell. 52 (3), 434-446 (2013).
  17. Thazhathveetil, A. K., Liu, S. T., Indig, F. E., Seidman, M. M. Psoralen conjugates for visualization of genomic interstrand cross-links localized by laser photoactivation. Bioconjugate Chemistry. 18 (2), 431-437 (2007).
  18. O'Donnell, M. E., Li, H. The ring-shaped hexameric helicases that function at DNA replication forks. Nature Structural & Molecular Biology. 25 (2), 122-130 (2018).
  19. Koos, B., et al. Analysis of protein interactions in situ by proximity ligation assays. Current Topics in Microbiology and Immunology. 377, 111-126 (2014).
  20. Huang, J., et al. Remodeling of Interstrand Crosslink Proximal Replisomes Is Dependent on ATR, FANCM, and FANCD2. Cell Reports. 27 (6), 1794-1808 (2019).
  21. Huang, J., et al. Single molecule analysis of laser localized psoralen adducts. Journal of Visualized Experiments. (122), e55541 (2017).
  22. Saldivar, J. C., Cortez, D., Cimprich, K. A. The essential kinase ATR: ensuring faithful duplication of a challenging genome. Nature Reviews Molecular Cell Biology. 18 (10), 622-636 (2017).
  23. Cortez, D., Glick, G., Elledge, S. J. Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. Proceedings of the National Academy of Sciences. 101 (27), 10078-10083 (2004).
  24. Ersoy, I., Bunyak, F., Chagin, V., Cardoso, M. C., Palaniappan, K. Segmentation and classification of cell cycle phases in fluorescence imaging. Medical Image Computing and Computer-Assisted. 12, 617-624 (2009).
  25. Zhao, J., Dynlacht, B., Imai, T., Hori, T., Harlow, E. Expression of NPAT, a novel substrate of cyclin E-CDK2, promotes S-phase entry. Genes & Development. 12 (4), 456-461 (1998).

Erratum


Formal Correction: Erratum: Visualization of Replisome Encounters with an Antigen Tagged Blocking Lesion
Posted by JoVE Editors on 1/09/2023. Citeable Link.

An erratum was issued for: Visualization of Replisome Encounters with an Antigen Tagged Blocking Lesion.

The Authors section was updated from:

Jing Zhang*1
Jing Huang*2
Ryan C. James3
Julia Gichimu1
Manikandan Paramasivam4
Durga Pokharel5
Himabindu Gali6
Marina A. Bellani1
Michael M Seidman1
1Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health
2Institute of Chemical Biology and Nanomedicine, State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan University
3Department of Molecular Biology and Genetics, Cornell University
4Department of Cellular and Molecular Medicine, University of Copenhagen
5Horizon Discovery
6Boston University School of Medicine
* These authors contributed equally

to:

Jing Zhang*1
Jing Huang*2
Ishani Majumdar1
Ryan C. James3
Julia Gichimu1
Manikandan Paramasivam4
Durga Pokharel5
Himabindu Gali6
Marina A. Bellani1
Michael M Seidman1
1Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health
2Institute of Chemical Biology and Nanomedicine, State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan University
3Department of Molecular Biology and Genetics, Cornell University
4Department of Cellular and Molecular Medicine, University of Copenhagen
5Horizon Discovery
6Boston University School of Medicine
* These authors contributed equally

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Replisome VisualizationAntigen tagged DNABlocking LesionImmunodetectionCell Cycle InteractionsIshani MajumdarSeidman LaboratoryCell Culture ProtocolUVA ExposureCytoskeleton Extraction BufferFormaldehyde FixationTriton X 100 Treatment

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved